...Huadong Xie; Yuanbi Huang; Huajie He; Rongchao Chen; Yongpeng Li; Haoyuan Lu; Xianlin Yi Introduction: The aim of this study was to assess the prognostic value of the preoperative serum ferritin-to-transferrin ratio (FTR) in renal cell carcinoma (RCC). Methods: We retrospectively reviewed data from...

... Introduction: Adjuvant pembrolizumab versus placebo significantly improved disease-free survival (DFS) in renal cell carcinoma (RCC) patients at high risk (HR) of recurrence following nephrectomy in KEYNOTE-564 trial (NCT03142334). The objective of this study was to evaluate efficacy and safety of adjuvant...

... inhibitor sunitinib in patients with advanced or metastatic renal cell carcinoma (a/mRCC) in a real-world setting. Methods: We analyzed data of adult a/mRCC patients treated with sunitinib. Data were derived from the German non-interventional post-approval multicenter STAR-TOR registry (NCT00700258...

...Jinbin Xu; ZhanSen Huang; ShunTian Gao; GengGuo Deng; Jinming Di Background: The aim of the study was to identify the cooperation of authors, countries, institutions and explore the hot spots regarding research of tyrosine kinase inhibitors (TKIs) for renal cell carcinoma (RCC) treatment...

...Xia Sun; Guang Wang; Ziye Huang; Pei Li; Bowei Yang; Tianyun Wang; Jiongming Li Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is a new subtype of RCC included in the 2016 edition of the WHO classification in RCC. SDH-defective RCC accounts for 0.05–0.2%, and preoperative...

..., instructions or products referred to in the content or advertisements. 2023 Focal therapy Renal cell carcinoma Population-based study Trends Ablation techniques Kidney Renal cell carcinoma (RCC) represents around 3% of all cancers and remains one of the most lethal urological malignancies...

... or metachronous oligometastatic renal cell carcinoma (RCC). Methods: The clinical data of 87 patients with 138 lesions who received MDT between February 2008 and January 2019 were retrospectively analyzed. All patients had ≤5 metastasis at diagnosis (synchronous) or during progression (metachronous) and were...

...Eva Bonetti; Maximilian Jenzer; Cathleen Nientiedt; Adam Kaczorowski; Christine Geisler; Stefanie Zschäbitz; Dirk Jäger; Markus Hohenfellner; Stefan Duensing; Philipp Reimold Introduction: Cytokine-based immunotherapy (IT) has been the mainstay of systemic treatment of advanced renal cell carcinoma...

... metastatic renal cell carcinoma (mRCC) patients treated with tyrosine kinase inhibitors (TKIs). Patients and Methods: mRCC patients treated with TKIs as first-line systemic therapy were retrospectively evaluated. The patients were determined as trial-ineligible when they met at least 1 following trial...

...Yixiu Ni; Xiaohua Yang Introduction: Robot-assisted partial nephrectomy (RAPN) has been increasingly used for renal cell carcinoma in recent years. But the advantages of RARN over open partial nephrectomy (OPN) are still controversial. Methods: We searched the articles between 1997 and 2021...

...Senyao Xue; Hui Zhao; Kaikai Zhang; Huapeng Zhang; Wei Wang Introduction: Prognostic nutritional index (PNI) was indicted as a potential prognostic biomarker for cancer. However, the conclusion remains uncertain for renal cell carcinoma (RCC). This study was to confirm the association of PNI...

...Kojiro Ohba; Yasuyoshi Miyata; Kensuke Mitsunari; Tsuyoshi Matsuda; Yuta Mukae; Yuichiro Nakamura; Tomohiro Matsuo; Hideki Sakai Introduction: We investigated the efficacy and safety of every-other-day dosing of sunitinib for the treatment of metastatic renal cell carcinoma (mRCC) with extended...

... renal cell carcinomas (RCCs) in conjunction with tumor thrombus between 2007 and 2011 were included. Open partial nephrectomy and thrombectomy was performed. Reconstruction included main renal vein, collecting system, and remaining parenchymal closure. One of the cases required additional artery repair...

... and function of Capns1 in human renal cell carcinoma (RCC) have not been clarified. This study aimed to examine the expression of Capns1 in RCC tissues and cell lines and to assess its role performed in RCC. Methods: Capns1 expression was evaluated in 75 pairs of RCC and matched adjacent non-tumor tissues...

...Ruotao Xiao; Chuxiao Xu; Liyuan Ge; Wei He; Bin Yang; Lei Liu; Cheng Liu; Lulin Ma Introductions: The objective of this study was to determine the prognostic value of positive lymph nodes (LNs) in patients with renal cell carcinoma (RCC) and tumor thrombus (TT) and to explore risk factors...

...Amalia Schiavetti; Eva Ferrara; Alessandra De Grazia; Denis A. Cozzi A 31-year-old man was referred to an adult urologist for a renal polar mass that measured 7.2 cm in maximum diameter. Robotic assisted complete tumor excision for suspicious renal cell carcinoma was carried out, preserving...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Kidney cancer Renal cell carcinoma Partial nephrectomy Nephrometry...

...Martin Bögemann; Aleksandra Zagorska; Divine Akumo; Laila El Hadad; Marc Pignot Objectives: To characterize real-world prescribing patterns and their clinical and healthcare resource utilization (HRU) implications in patients with metastatic renal cell carcinoma (mRCC) treated in Germany. Methods...

...Mandy Hubatsch; Robert Peters; Andreas Maxeiner; Nasrin El-Bandar; Sarah Weinberger; Frank Friedersdorff We report 2 cases of de novo renal cell carcinoma (RCC) in renal grafts after transplantation. Both patients underwent nephron sparing surgery (NSS) 211 and 167 months after transplantation...

...Ming Li; Renge Bu Obesity is a proven risk factor and a debated prognostic factor in renal cell carcinoma (RCC). Termed as an “obesity paradox,” the topic has churned controversies, with a few arguing of no true biological association. Suggesting otherwise, a few studies revealed adiposity-induced...